Dasatinib may overcome the negative prognostic impact of KIR2DS1 in newly diagnosed patients with chronic myeloid leukemia

Gardado en:
Detalles Bibliográficos
Publicado en:Blood
Main Authors: Ali, Sara, Sergeant, Ruhena, O'Brien, Stephen G., Foroni, Letizia, Hedgley, Corinne, Gerrard, Gareth, Milojkovic, Dragana, Stringaris, Kate, Khoder, Ahmad, Alsuliman, Abdullah, Gilleece, Maria, Gabriel, Ian H., Cooper, Nichola, Goldman, John M., Apperley, Jane F., Clark, Richard E., Marin, David, Rezvani, Katayoun
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2012
Assuntos:
Correspondence
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6143148/
https://ncbi.nlm.nih.gov/pubmed/22822001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-04-421016
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares